Ephrin Eph Signaling Pathway In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.
The Eph family of receptor tyrosine kinases and their ephrin ligands are key regulators of cell positioning, synaptic plasticity, and developmental patterning. The Eph/ephrin system mediates bidirectional signaling that controls axonal guidance, synapse formation, and neural circuit assembly. In neurodegenerative diseases, Eph/ephrin signaling is dysregulated and contributes to synaptic dysfunction, impaired regeneration, and neuroinflammation. Understanding this pathway offers therapeutic opportunities for conditions like Alzheimer's disease, Parkinson's disease, and stroke.
| Receptor |
Expression |
Primary Ligands |
Key Functions |
| EphA1 |
Various |
Ephrin-A1, A2, A3, A4, A5 |
Development, cancer |
| EphA2 |
Neurons, epithelium |
Ephrin-A1, A2, A3, A4 |
Angiogenesis, adhesion |
| EphA3 |
Brain |
Ephrin-A2, A5 |
Synaptic plasticity |
| EphA4 |
Neurons, glia |
Ephrin-A2, A3, A5, A6 |
Synapse, regeneration |
| EphA5 |
Neurons |
Ephrin-A2, A3, A5 |
Development |
| EphA6 |
Brain |
Ephrin-A2, A3, A5 |
Unknown |
| EphA7 |
Brain |
Ephrin-A2, A3, A4, A5 |
Development |
| EphA8 |
Brain |
Ephrin-A2, A5 |
Development |
| EphB1 |
Various |
Ephrin-B1, B2, B3 |
Development |
| EphB2 |
Neurons |
Ephrin-B1, B2, B3 |
Synapse, memory |
| EphB3 |
Various |
Ephrin-B1, B2, B3 |
Development |
| EphB4 |
Endothelium |
Ephrin-B2 |
Angiogenesis |
| EphB6 |
Thymus |
Ephrin-B1, B2, B3 |
Immune function |
¶ Ephrin Ligands
- Ephrin-A ligands (EFNA1-5): GPI-anchored, bind EphA receptors
- Ephrin-B ligands (EFNB1-3): Transmembrane, bind EphB receptors
flowchart TD
subgraph "Forward Signaling (Eph on Signal-Receiving Cell)"
A[Ephrin-A/B] --> B[Eph Receptor]
B --> C[RTK Activation]
C --> D[Adaptor Proteins]
D --> E[PI3K/Akt Pathway]
D --> F[MAPK/ERK Pathway]
D --> G[Rho GTPases]
E --> H[Cell Adhesion<br>Migration]
F --> I[Proliferation<br>Differentiation]
G --> J[Cytoskeleton<br>Shape Change]
end
subgraph "Reverse Signaling (Ephrin on Signal-Sending Cell)"
K[Eph Receptor] --> L[Ephrin Ligand]
L --> M[PDZ Domain<br>Proteins]
M --> N[Src Family<br>Kinases]
N --> O[Signal Transduction]
end
H --> P[Synaptic<br>Plasticity]
I --> P
J --> P
O --> P
| Pathway |
Effectors |
Functions |
| PI3K/Akt |
PDK1, mTOR |
Cell survival, protein synthesis |
| MAPK/ERK |
RAF, MEK, ERK |
Proliferation, differentiation |
| Rho GTPases |
Rac, Rho, Cdc42 |
Cytoskeleton dynamics |
| Src |
Fyn, Src |
Adhesion, migration |
EphB2 is critically involved in synaptic function:
- Synaptic localization: EphB2 is enriched at excitatory synapses
- NMDA receptor interaction: EphB2 regulates NMDA receptor function
- Aβ-induced dysfunction: Aβ reduces EphB2 expression and disrupts signaling
- Memory impairment: Restoring EphB2 reverses memory deficits in AD models
- Ephrin-A5 modulates amyloid precursor protein (APP) processing
- EphA4 activation contributes to synaptic loss
- Therapeutic targeting of EphA4 being explored
¶ Regeneration and Plasticity
- Impaired Eph/ephrin signaling contributes to regenerative failure
- Blocking EphA4 promotes axon regeneration after injury
- EphB receptors regulate development of dopaminergic neurons
- Axonal guidance molecules influence substantia nigra connectivity
- Dysregulated EphB signaling affects striatal synapse function
- Contributes to basal ganglia circuit dysfunction
¶ Role in Stroke and Brain Injury
- EphA/ephrin-A signaling is upregulated after stroke
- Mediates post-ischemic inflammation and angiogenesis
- Bidirectional signaling affects both neurons and vasculature
- Manipulating Eph/ephrin signaling promotes or inhibits regeneration
- EphA4 antagonists improve functional recovery
- EphB signaling affects motor neuron development and synapse formation
- Dysregulation contributes to neuromuscular junction disruption
| Approach |
Target |
Status |
| EphA4 antagonists |
EphA4 |
Preclinical |
| EphB2 agonists/modulators |
EphB2 |
Preclinical |
| Soluble Eph receptors |
Multiple |
Preclinical |
| Peptide agonists |
Multiple |
Preclinical |
- Complexity: Multiple receptors and ligands with overlapping functions
- Bidirectional signaling: Both forward and reverse signals must be considered
- Cell-type specificity: Achieving cell-type selective targeting
The study of Ephrin Eph Signaling Pathway In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Murai KK, Pasquale EB. Eph/ephrin signaling in the formation of the central nervous system. Neuroscientist. 2004
- Klein R. Eph/ephrin signaling in brain development and disease. Neuron. 2012
- Xu NJ, Henkemeyer M. Ephrin-B3 binding and cognitive function. Nat Rev Neurosci. 2012
- Coon AL, et al. EphB2 in hippocampal synaptic plasticity and memory. J Neurosci. 2019
- Fu AK, et al. EphA4 mediates Aβ-induced synaptic dysfunction. Nat Commun. 2018
- Murai KK, et al. Control of hippocampal synaptic plasticity by EphB2. Nat Neurosci. 2003
- Chen Y, et al. EphA4 promotes regeneration after stroke. J Cereb Blood Flow Metab. 2019
- Liu J, et al. Role of EphB2 in Alzheimer's disease. Prog Neurobiol. 2020
- Cox BD, et al. Targeting Eph/ephrin signaling in CNS disorders. Expert Opin Ther Targets. 2020
- Nakanishi H, et al. Bidirectional Eph-ephrin signaling in neural development. Dev Neurobiol. 2021
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
10 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 31%